BodyScan 2: The Scale That Predicts How Long You'll Live

Longevity Measurement Through Multiple Biomarker Tracking

Traditional smart scales measure weight and basic body composition without assessing cardiovascular health or early disease indicators. Withings developed BodyScan 2, a connected scale combining multiple medical-grade sensing technologies to capture over 60 biomarkers in a single 90-second measurement session. The smart scale integrates impedance cardiography to measure how efficiently the heart pumps blood throughout the body, bioimpedance spectroscopy to assess cellular health and metabolic function, and electrocardiography to detect irregular heart rhythms. This comprehensive longevity biomarker approach provides early detection of health imbalances that might progress into hypertension, diabetes, or heart failure if left unaddressed.

BodyScan 2 measures health trajectories through longitudinal biomarker tracking, meaning repeated measurements over weeks and months reveal health trends rather than single-point snapshots. The device creates a Health Trajectory score synthesizing all biomarker data into a single predictive metric representing estimated years of healthy life. This smart scale tracks how daily choices, including diet, activity, sleep, and stress accumulation, may affect healthspan, providing actionable insights for preventive health management.

Advanced Cardiovascular Assessment Technologies

BodyScan 2 contains twelve electrodes, creating a full-body measurement circuit with four electrodes in the retractable handle and eight electrodes embedded in the tempered glass surface. This multi-point electrode arrangement allows the smart scale to create complete measurement pathways through arms, torso, abdomen, and legs, enabling direct measurement of cellular properties rather than estimation. Unlike traditional foot-only smart scales relying on bioimpedance assumptions, BodyScan 2 penetrates cell membranes using ultra-high-frequency signals for unparalleled measurement precision.

Impedance cardiography measures cardiac output and heart pumping efficiency, revealing how effectively the heart delivers oxygen-rich blood to organs. Low cardiac output often produces silent symptoms, including fatigue, poor stress response, and reduced exercise capacity that users might attribute to other causes. Early detection of declining cardiac efficiency enables lifestyle adjustments before more serious cardiovascular complications emerge. The smart scale also calculates Heart Age, a strong predictor of overall vitality and longevity, representing the cardiovascular aging trajectory compared to chronological age.

The six-lead ECG component detects atrial fibrillation, the most common cardiac arrhythmia, and provides real-time heart rhythm assessment. BodyScan 2 evaluates vascular elasticity through arterial stiffness measurement, identifying how blood vessels respond to daily lifestyle factors. A clinically validated artificial intelligence model estimates blood pressure trends based on each scan without requiring a separate blood pressure cuff, providing early warning for hypertension—one of the most underdiagnosed adult health risks.

Cellular and Metabolic Analysis

Bioimpedance spectroscopy analyzes metabolism at the cellular level, where energy is transformed and stored within individual cells. This cellular assessment enables early detection of metabolic slowdown or inflammatory states that precede metabolic dysfunction. BodyScan 2 provides six-zone body composition analysis, breaking down muscle and fat distribution across different body regions, offering more detailed segmentation than traditional whole-body measurements.

The smart scale introduces Cellular Age assessment, a novel metric quantifying biological cellular aging independently from chronological age. Chronic stress periods, sedentary routines, and visceral abdominal fat accumulation can accelerate cellular aging. BodyScan 2 measures glycemic impact, revealing how individual dietary choices affect glucose regulation and metabolic stability. This glycemic impact detection identifies early signs of dysregulation that may progress toward prediabetes, enabling intervention through nutrition modification before clinical disease develops. The device also calculates a Nerve Response Score, detecting early nerve damage years before clinical symptoms appear.

Design and Data Security

BodyScan 2 features a color display integrated directly into the retractable handle, allowing users to view results immediately after measurement without requiring smartphone access. The tempered glass surface provides a premium feel while supporting the embedded electrodes. Users can customize which biomarkers to track and receive personalized health coaching prompts through built-in artificial intelligence. The smart scale operates in automatic scanning mode once users step on it, requiring no additional setup or button pressing.

All health data is encrypted end-to-end and stored in compliance with strict privacy regulations, including GDPR and HIPAA guidelines. Withings maintains ISO 27001 and ISO 27701 certifications for data protection, setting a global standard for health data security rarely seen in consumer health technology. Users maintain full control over their information at all times, with data syncing capability to companion applications and Apple Health.